Cargando…

Proteomic signatures corresponding to the SS18/SSX fusion gene in synovial sarcoma

Synovial sarcoma (SS) is a malignant soft tissue lesion and most commonly arises in young adults. Chromosomal translocation t(X;18)(p11;q11) results in the formation of SS18/SSX by gene fusion of the SS18 gene on chromosome 18 to either SSX1, SSX2, or SSX4 gene located on chromosome X, which is dete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishii, Midori, Suehara, Yoshiyuki, Sano, Kei, Kohsaka, Shinji, Hayashi, Takuo, Kazuno, Saiko, Akaike, Keisuke, Mukaihara, Kenta, Kim, Youngji, Okubo, Taketo, Takamochi, Kazuya, Takahashi, Fumiyuki, Kaneko, Kazuo, Saito, Tsuyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331019/ https://www.ncbi.nlm.nih.gov/pubmed/30680066 http://dx.doi.org/10.18632/oncotarget.26493

Ejemplares similares

PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma
por: Akaike, Keisuke, et al.
Publicado: (2018)

IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing’s sarcoma
por: Tanabe, Yu, et al.
Publicado: (2018)

Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab
por: Mukaihara, Kenta, et al.
Publicado: (2016)

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma
por: Mukaihara, Kenta, et al.
Publicado: (2017)

SS18-SSX drives CREB activation in synovial sarcoma
por: Cyra, Magdalene, et al.
Publicado: (2022)

KCTD12 is negatively regulated by Kit in gastrointestinal stromal tumors
por: Suehara, Yoshiyuki, et al.
Publicado: (2018)

The clinical implication of SS18-SSX fusion gene in synovial sarcoma
por: Ren, T, et al.
Publicado: (2013)

Truncated SSX Protein Suppresses Synovial Sarcoma Cell Proliferation by Inhibiting the Localization of SS18-SSX Fusion Protein
por: Yoneda, Yasushi, et al.
Publicado: (2013)

Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases
por: Takagi, Tatsuya, et al.
Publicado: (2015)

Expanding the Use of an SS18-SSX Antibody for Molecular Assays in Synovial Sarcoma
por: Raquib, Ainiah Rushdiana, et al.
Publicado: (2022)

Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors
por: Kurihara, Taisei, et al.
Publicado: (2020)

Expression of F-actin-capping protein subunit beta, CAPZB, is associated with cell growth and motility in epithelioid sarcoma
por: Mukaihara, Kenta, et al.
Publicado: (2016)

Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance
por: Kim, Youngji, et al.
Publicado: (2016)

Usefulness of SS18-SSX antibody as a diagnostic marker for pulmonary metastatic synovial sarcoma
por: Miura, Kentaro, et al.
Publicado: (2021)

Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases
por: Przybyl, Joanna, et al.
Publicado: (2012)

Prognostic value of SS18–SSX fusion type in synovial sarcoma; systematic review and meta-analysis
por: Kubo, Tadahiko, et al.
Publicado: (2015)

Cooperation between SS18-SSX1 and miR-214 in Synovial Sarcoma Development and Progression
por: Tanaka, Miwa, et al.
Publicado: (2020)

Phase transition and remodeling complex assembly are important for SS18-SSX oncogenic activity in synovial sarcomas
por: Cheng, Yanli, et al.
Publicado: (2022)

TERT promoter mutations are a rare event in gastrointestinal stromal tumors
por: Akaike, Keisuke, et al.
Publicado: (2015)

SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1
por: Minami, Yusuke, et al.
Publicado: (2014)

Transcription start site‐level expression of thyroid transcription factor 1 isoforms in lung adenocarcinoma and its clinicopathological significance
por: Sano, Kei, et al.
Publicado: (2021)

SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier
por: Tamaki, Sakura, et al.
Publicado: (2015)

Detection of SS18-SSX1/2 fusion transcripts in circulating tumor cells of patients with synovial sarcoma
por: Przybyl, Joanna, et al.
Publicado: (2019)

A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18–SSX Induces Canonical BAF Destruction
por: Li, Jinxiu, et al.
Publicado: (2021)

Detection of circulating sarcoma tumor cells using a microfluidic chip-type cell sorter
por: Hasegawa, Nobuhiko, et al.
Publicado: (2019)

β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition
por: Barrott, Jared J., et al.
Publicado: (2015)

SYT-SSX fusion genes and prognosis in synovial sarcoma
por: Mezzelani, A, et al.
Publicado: (2001)

Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma
por: Sasa, Keita, et al.
Publicado: (2022)

MDM2 amplification and fusion gene ss18-ssx in a poorly differentiated synovial sarcoma: A rare but puzzling conjunction
por: Di Mauro, Ilaria, et al.
Publicado: (2020)

Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma
por: Sasa, Keita, et al.
Publicado: (2022)

RETRACTED ARTICLE: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma
por: Sasa, Keita, et al.
Publicado: (2021)

Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma
por: Peng, Changliang, et al.
Publicado: (2016)

Primary monophasic synovial sarcoma of the cervical esophagus confirmed by detection of the SS18-SSX2 fusion transcripts: case report and literature review
por: Sasaki, Ken, et al.
Publicado: (2020)

The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma
por: Cironi, Luisa, et al.
Publicado: (2016)

Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma
por: Kawaguchi, Satoshi, et al.
Publicado: (2005)

The Synovial Sarcoma-Associated SYT-SSX2 Oncogene Antagonizes the Polycomb Complex Protein Bmi1
por: Barco, Roy, et al.
Publicado: (2009)

Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability
por: Benabdallah, Nezha S., et al.
Publicado: (2023)

Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2
por: Garcia, Christina B, et al.
Publicado: (2012)

Deflection of vascular endothelial growth factor action by SS18–SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma
por: Wakamatsu, Toru, et al.
Publicado: (2014)

SSX expression and function in prostate cancer
por: Bloom, Jordan E, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bbadrql0b24n5ulf03aa1dotir